REG - Alliance Pharma PLC Aviva PLC - TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES <Origin Href="QuoteRef">ALAPH.L</Origin> <Origin Href="QuoteRef">AV.L</Origin>

AvivaAnnouncement

09/12/2016 11:50

RNS Number : 4667R
Alliance Pharma PLC
09 December 2016

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES


1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
Alliance Pharma plc 
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights 

Other (please specify):

3. Full name of person(s) subject to the
notification obligation:
Aviva plc & its subsidiaries 
4. Full name of shareholder(s)
(if different from 3.):
Registered Holder:
 
Available on request 18,450*
BNY Norwich Union Nominees Limited 2,682,600*
Chase (GA Group) Nominees Limited 39,403,058*
 
*denotes direct interest
Chase Nominees Limited 1,361,894
5. Date of the transaction and date on
which the threshold is crossed or
reached:
6 December 2016
6. Date on which issuer notified:
8 December 2016
7. Threshold(s) that is/are crossed or
reached:
9% to 8% Change at Direct Interest Level (Box 8A & 8B)
8. Notified details:
A: Voting rights attached to shares
Class/type of
shares

if possible using
the ISIN CODE
Situation previous
to the triggering
transaction
Resulting situation after the triggering transaction
Number
of
Shares
Number
of
Voting
Rights
Number
of shares
Number of voting
rights
% of voting rights 
Direct
Direct
Indirect 
Direct
Indirect
Ordinary Shares

GB0031030819
44,241,981*
44,241,981*
43,466,002
42,104,108
1,361,894
8.92%
0.29%

* Includes Right to Recall Loaned Shares (108,293)
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument
Expiration
date 
Exercise/
Conversion Period 
Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.
% of voting
rights
RIGHT TO RECALL LOANED SHARES
N/A
N/A
108,293*
*Direct Interest
0.02%
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments 
Resulting situation after the triggering transaction
Type of financial
instrument
Exercise price
Expiration date
Exercise/
Conversion period
Number of voting rights instrument refers to
% of voting rights





Nominal
Delta


Total (A+B+C)
Number of voting rights
Percentage of voting rights
43,574,295
9.23%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: 
The voting rights are managed and controlled by Aviva Investors Global Services Limited and Friends Provident International Limited, with the following chain of controlled undertakings:-
Aviva Investors Global Services Limited:
 Aviva plc (Parent Company)
 Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)
 Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited)
 Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)
Friends Provident International Limited:
 Aviva plc (Parent Company)
 Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)
 Aviva Life Holdings UK Limited (wholly owned subsidiary of Aviva Group Holdings Limited)
 Friends Life FPG Limited (wholly owned subsidiary of Aviva Life Holdings UK Limited)
 Friends Life FPL Limited (wholly owned subsidiary of Friends Life FPG Limited)
 Friends Life Limited (wholly owned subsidiary of Friends Life FPL Limited)
 Friends Life and Pensions Limited (wholly owned subsidiary of Friends Life Limited)
 Friends Provident International Limited (wholly owned subsidiary of Friends Life and Pensions Limited)

Proxy Voting:
10. Name of the proxy holder:
See Section 4
11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:



13. Additional information:

Figures are based on a total number of voting rights of 471,983,986, as per the Company's Exercise of Share Options announcement of 23rd November 2016.
14. Contact name:
 James Clark, Aviva plc
15. Contact telephone number:
 01603 683853

This information is provided by RNS
The company news service from the London Stock Exchange
  END
HOLFKLFBQLFZFBF